GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2007

DoD Taps Ichor for Biodefense Vaccine

  • Ichor Medical Systems was awarded a two-year contract valued at over $900,000 to develop a DNA vaccine for equine encephalitis. The funding from the DoD extends Ichor's existing relationship with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

    According to CEO Bob Bernard, Ichor will collaborate with Connie Schmaljohn, senior research scientist at USAMRIID, to evaluate an array of vaccine candidates administered using Ichor's TriGrid DNA vaccine delivery system. 

    "Ichor's TriGrid Delivery System dramatically enhances the magnitude and consistency of immune responses following DNA vaccination, both of which have a critical role in vaccine efficacy,” states Bernard.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »